AJR InPractice
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hinshaw, J. L.
Right arrow Articles by Lee, F. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hinshaw, J. L.
Right arrow Articles by Lee, F. T., Jr.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.05.0140
AJR 2006; 186:S306-S310
© American Roentgen Ray Society


Original Research

Radiofrequency Ablation of Peripheral Liver Tumors: Intraperitoneal 5% Dextrose in Water Decreases Postprocedural Pain

J. Louis Hinshaw1, Paul F. Laeseke1, Thomas C. Winter, III1, Mark A. Kliewer1, Jason P. Fine1 and Fred T. Lee, Jr.1

1 All authors: Department of Radiology, University of Wisconsin, E3/311 CSC, 600 Highland Ave., Madison, WI 53792.

OBJECTIVE. Our objective was to evaluate the clinical efficacy of the intraperitoneal instillation of 5% dextrose in water (D5W) during radiofrequency ablation of peripheral liver tumors for decreasing postradiofrequency pain and narcotic use.

MATERIALS AND METHODS. This case-control study compared the hospital course of the last 20 patients to undergo radiofrequency ablation of peripheral liver tumors at our institution. Ten consecutive subjects in the D5W group (seven women and three men; age range, 37-78 years; mean, 58 years) were pretreated with intraperitoneal D5W (average, 963 ± 436 [SD] mL) before the ablation. This group was compared with a control group of 10 patients (five men and five women; age range, 36-73 years; mean, 54 years) who did not receive intraperitoneal D5W. The size of the ablation zone, degree of liver capsule involvement, number of burns, patient-reported pain, patient-controlled analgesia use, and length of hospital stay were recorded and compared between the groups.

RESULTS. The patients in the D5W group reported significantly less pain in the first 24 hr after the procedure than did the controls (2.3 vs 6.3, p = 0.003) despite a significant decrease in patient-controlled analgesia use (17.3 vs 125.1 mg of morphine, p = 0.003). The differences in pain and patient-controlled analgesia use were greatest in the first 16 hr and decreased over time in both groups. The total volume of ablation (61.9 vs 45.2 cm3, p = 0.44), liver surface involvement (6.2 vs 6.0 cm, p = 0.73), and number of burns (1.8 vs 1.1, p = 0.14) were slightly higher in the D5W group than in the control group, but this difference was not statistically significant.

CONCLUSION. Pretreatment with intraperitoneal D5W before radiofrequency ablation of peripheral liver tumors decreased pain, narcotic use, and length of hospital stay. The effect of pretreatment with D5W is greatest in the first 16 hr after the procedure.

Keywords: interventional radiology • liver • percutaneous ablation • radiofrequency ablation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
S. Lee, H. Rhim, Y.-S. Kim, D. Choi, W. J. Lee, H. K. Lim, and B. Shin
Percutaneous Radiofrequency Ablation of Hepatocellular Carcinomas: Factors Related to Intraprocedural and Postprocedural Pain
Am. J. Roentgenol., April 1, 2009; 192(4): 1064 - 1070.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. L. Hinshaw, A. M. Shadid, S. Y. Nakada, S. P. Hedican, T. C. Winter III, and F. T. Lee Jr.
Comparison of Percutaneous and Laparoscopic Cryoablation for the Treatment of Solid Renal Masses
Am. J. Roentgenol., October 1, 2008; 191(4): 1159 - 1168.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. Sartori, P. Tombesi, F. Macario, I. Nielsen, D. Tassinari, M. Catellani, and V. Abbasciano
Subcapsular Liver Tumors Treated with Percutaneous Radiofrequency Ablation: A Prospective Comparison with Nonsubcapsular Liver Tumors for Safety and Effectiveness
Radiology, August 1, 2008; 248(2): 670 - 679.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
H. Rhim, H. K. Lim, Y.-s. Kim, and D. Choi
Percutaneous Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in the Hepatic Dome: Initial Experience
Am. J. Roentgenol., January 1, 2008; 190(1): 91 - 98.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. L. Hinshaw, P. J. Laeseke, S. M. Weber, and F. T. Lee Jr.
Multiple-Electrode Radiofrequency Ablation of Symptomatic Hepatic Cavernous Hemangioma
Am. J. Roentgenol., September 1, 2007; 189(3): W146 - W149.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
P. F. Laeseke, T. M. Frey, C. L. Brace, L. A. Sampson, T. C. Winter III, J. R. Ketzler, and F. T. Lee Jr.
Multiple-Electrode Radiofrequency Ablation of Hepatic Malignancies: Initial Clinical Experience
Am. J. Roentgenol., June 1, 2007; 188(6): 1485 - 1494.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.